Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06527794

Remote Hypertension Management for Black Patients

Remote Hypertension Tracking, Help, and Management to Reduce Disparities in Black Patients

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
864 (estimated)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
All
Age
21 Years – 85 Years
Healthy volunteers
Not accepted

Summary

This study will compare two approaches for managing hypertension in Black patients with uncontrolled blood pressure (BP). One approach will include home BP telemonitoring supported by a pharmacist and a community health worker. The other approach will include usual clinic-based care along with a home BP monitor and routine care.

Detailed description

This study is a pragmatic effectiveness-implementation hybrid type 2 trial with two study arms. One arm will include home BP telemonitoring supported by a pharmacist and a community health worker providing centralized self-management support. The other arm will include enhanced usual clinic-based care with a home BP monitor and routine care from providers trained on evidence-based guidelines.

Conditions

Interventions

TypeNameDescription
BEHAVIORALRHYTHM (Remote Hypertension Tracking Help Management)Home blood pressure telemonitoring with remote medication management by a centralized multidisciplinary team led by a pharmacist; and social support, lifestyle education and connection to community resources to address social needs, provided by a community health worker who is embedded with the centralized team and is tightly connected to community resources and partners
BEHAVIORALEnhanced usual care (UC)All participating sites will receive training on appropriate blood pressure measurement and education on guideline-based hypertension therapy. Additionally, participants in usual care will receive a standardized packet with evidence-based hypertension education material and a blood pressure monitor to complete blood pressure measurements at home.

Timeline

Start date
2024-12-13
Primary completion
2028-09-01
Completion
2028-09-01
First posted
2024-07-30
Last updated
2025-06-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06527794. Inclusion in this directory is not an endorsement.